| Do people with intellectual disabilities understand their prescription medication? A scoping review MVA Smith, D Adams, C Carr, SE Mengoni Journal of Applied Research in Intellectual Disabilities 32 (6), 1375-1388, 2019 | 28 | 2019 |
| Prescribing of psychotropic medicines: The role of learning disability nurses D Adams, C Shah Learning Disability Practice 19 (8), 2016 | 13 | 2016 |
| An update on informed consent and the effect on the clinical practice of those working with people with a learning disability D Adams, C Carr, D Marsden, K Senior Learning Disability Practice 23 (3), 2020 | 7 | 2020 |
| Deprescribing of psychotropic medication in a 30-year-old man with learning disability D Adams, I Sawhney European Journal of Hospital Pharmacy 24 (1), 63-64, 2017 | 5 | 2017 |
| Deprescribing psychotropic medicines for behaviours that challenge in people with intellectual disabilities: a systematic review D Adams, RP Hastings, I Maidment, C Shah, PE Langdon BMC psychiatry 23 (1), 1-43, 2023 | 3 | 2023 |
| Reducing antipsychotic prescribing in people with learning disabilities D Adams, C Shah Clinical Pharmacist 8 (10), 000-000, 2016 | 3 | 2016 |
| Polypharmacy and deprescribing in people with learning disabilities D Adams Practice Nursing 30 (8), 386-389, 2019 | 2 | 2019 |
| The implications of the Montgomery judgment on pharmacy practice and patients with learning disability C Carr, D Adams The Pharmaceutical Journal, 2017 | 2 | 2017 |
| Stakeholder experiences of deprescribing psychotropic medicines for challenging behaviour in people with intellectual disabilities D Adams, RP Hastings, I Maidment, C Shah, PE Langdon Tizard Learning Disability Review, 2024 | 1 | 2024 |
| Using clinical audit to improve the quality of mental health-care services for people with learning disabilities E da Costa, D Adams, M Salmeh, O Mahmoud, E Yetkili Advances in Mental Health and Intellectual Disabilities 15 (4), 105-118, 2021 | 1 | 2021 |
| Medication D Adams, B Jubraj Promoting the Health and Well-Being of People with Learning Disabilities, 89-106, 2020 | 1 | 2020 |
| Use of valproate: Implications for women with intellectual disabilities and the wider interdisciplinary healthcare team I Sawhney, A Zia, D Adams, B Gates British Journal of Learning Disabilities 47 (3), 195-200, 2019 | 1 | 2019 |
| Bone health and people with a learning disability who are prescribed epilepsy medication I Sawhney, D Adams, A Zia Learning Disability Practice (2014+) 20 (5), 23, 2017 | 1 | 2017 |
| Prescribing for people with a learning disability D Adams, B Jubraj Prescriber 34 (8-9), 23-27, 2023 | | 2023 |
| Medication support interventions for people with a learning disability: a mixed methods evidence synthesis Review protocols J Gauly, I Ghosh, A Brown, D Adams, S Flynn, K Martin, S Patterson, ... | | 2022 |
| Issues related to medication usage experienced by people with a learning disability and their carers and interventions to address them: A scoping review J Gauly, I Ghosh, A Brown, D Adams, S Flynn, K Martin, S Patterson, ... OSF Preprints, 2022 | | 2022 |
| 7.2 Initial Reflections D Adams, B Jubraj Promoting the Health and Well-Being of People with Learning Disabilities, 89, 2020 | | 2020 |
| Attention deficit hyperactivity disorder in adults and the role of the mental health nurse D Adams, J Padmore, P Singh British Journal of Mental Health Nursing 8 (1), 22-27, 2019 | | 2019 |
| Update on informed consent to treatment and impact on clinical practice of healthcare professionals working with people with learning disability D Adams, D Marsden, K Senior Learning Disability Practice 21 (4), 36-40, 2018 | | 2018 |
| EAHP Statement 6: Education and Research S Shora, D Adams Eur J Hosp Pharm 24, 69-70, 2017 | | 2017 |
